Richmond Pharmacology is excited to join the PNS Congress 2026 in Maastricht, The Netherlands, on 12- 15 June 2026.

Bringing together global leaders in peripheral nerve research and clinical care, this meeting serves as a key platform for advancing understanding of neuromuscular disorders, accelerating therapeutic innovation, and fostering collaboration between academia, industry, and patient organizations.

Representing Richmond Pharmacology

Dr Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Advances in peripheral nerve disorder research and treatment
  • Translational approaches for early-phase drug development
  • Regulatory considerations for innovative therapies
  • Patient-centric trial design and recruitment strategies
  • Strengthening partnerships across academia, industry, and advocacy groups

Connect With Us

If you are attending the PNS Annual Meeting 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Richmond Pharmacology Appoints Adam Hurd as Operations Director

August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read more

Upcoming Event

Women's Health Horizons 2026

22 September 2026
Richmond Pharmacology is pleased to join the Women’s Health Horizons London Summit hosted by the Royal College of Obstetricians and Gynaecologists in London, 22 September 2026
View event